Navigation Links
Ottawa researcher named 2013 Champion of Genetics
Date:5/8/2013

May 8, 2013, Victoria BC - The Canadian Gene Cure Foundation (CGCF), a national, charitable foundation committed to enabling Canadians to lead the world in the discovery and advancement of cures for inherited diseases, has honoured Dr. Alex MacKenzie by naming him a 2013 Champion of Genetics.

The CGCF Champion of Genetics award both honours the work of Canada's established scientists and provides support, inspiration and encouragement to bright young researchers in the early years of their careers.

This year, the CGCF Champions of Genetics nominating committee has honoured Dr. MacKenzie, along with four other scientists, for the significant contribution they have made in translational research. The chosen Champions also must be active mentors with a history of encouraging and enabling students in the field of genetics, and they must be active researchers, continuing to contribute to the Canadian genetics community.

CGCF Board Chair Sandra MacPherson said: "The CGCF Champions of Genetics are highly regarded both at home in Canada, and internationally. Not only are they excellent role models for aspiring young scientists, they are also continuing to work on the forefront of discoveries in the field of genetics. With the focus this year on translational medicine, CGCF is proud to be honouring scientists that have taken their work out of the lab and into patient care. They are Champions in the research community and also to the many families they have helped through their work."

Alex MacKenzie is principal investigator of the Apoptosis Research Centre at the Children's Hospital of Eastern Ontario and a professor in the Department of Pediatrics at the University of Ottawa. Dr. MacKenzie and his team have focused their research on inherited disorders and orphan diseases in children, identifying gene subsets for three disorders Duchenne muscular dystrophy, myotonic dystrophy, and spinal muscular atrophy (SMA). Dr. MacKenzie is a specialist in the field of SMA, a fatal neurodegenerative disease that often ends lives before age two.

"Our Champions are playing a crucial role in maintaining the reputation of Canada as a world leader in the field of genetics and molecular genomics," said CGCF board member Dr. Anny Fortin. "Dr. MacKenzie's involvement as a research scientist, medical doctor, advocate and spokesperson for the cause of spinal muscular atrophy (FightSMA) makes him one of the greatest examples of knowledge translation in Canada."

As part of the honour of being named a Champion of Genetics, Dr. MacKenzie was given the opportunity to nominate an individual he has personally mentored to apply for a $90,000 Champions of Genetics: Building the Next Generation Grant. The grant, made possible with the help of our funding partner the CIHR- Institute of Genetics, will provide much needed funding for the chosen young scientists. It will provide them the opportunity to advance their own exciting genetic research and discoveries and to mentor yet the next generation of scientists, perpetuating Canada's level of excellence in genetic research.

Also honoured by the Canadian Gene Cure Foundation along with Dr. MacKenzie were:

Dr. Bartha Knoppers, Canada Research Chair in Law and Medicine at McGill University; Director of the Centre of Genomics and Polity, Faculty of Medicine, Department of Human Genetics; Chair of the Ethics Working Party of the International Stem Cell Forum; Co-Chair of the Sampling/ELSI Committee of the 1000Genomes Project and a Member of the Scientific Steering Committee of the International Cancer Genome Consortium.

Dr. Steven Narod, Senior Scientist, Women's College Research Institute; Director, Familial Breast Cancer Research Unit, Women's College Research Institute; Professor, Dalla Lana School of Public Health, University of Toronto; Professor, Department of Medicine, University of Toronto; Tier 1 Canada Research Chair in Breast Cancer.

Dr. Alexey Pshezhetsky, Professor, Dept. of Pediatrics and Biochemistry, University of Montreal; Researcher, Dept. of Medical Genetics, Ste-Justine Hospital Research Center; Scientific Director of Medical Genetics Diagnostic Laboratory and Director of the Lysosomal Biology lab at Ste-Justine Hospital Research Center.

Dr. David S. Rosenblatt, professor of Human Genetics, Medicine, Pediatrics, and Biology at McGill University in Montral and chair of the university's Department of Human Genetics for the past 11 years. He is a Fellow of the Canadian Academy of Health Sciences and a Correspondant tranger of the Acadmie Nationale de Mdecine of France.


'/>"/>

Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute
Source:Eurekalert

Related medicine news :

1. Paul McCartney Tickets: Paul McCartney Tickets in Kanata Ottawa at the Scotiabank Place Go on Sale on Friday, April 26th at 10:00 a.m. Local Time
2. TEAL Ottawa Launches Skin Imperfection Treatments by Thermo LO
3. Don’t Compromise Your Health, Ottawa Residents!
4. Duke researchers describe how breast cancer cells acquire drug resistance
5. McAdams DeMarco Awarded $100,000 as First Arthritis-Aging Collaborative Researcher
6. CWRU School of Medicine researchers discover new target for personalized cancer therapy
7. U of M researchers discover link between heart, blood, and skeletal muscle
8. Researchers determine where best to place defibrillators
9. Researchers plot locations where AEDs could save more lives
10. Gene Mutation Linked to Migraines, Researchers Say
11. Discovery of New Cause of Congenital Hydrocephalus Opens the Door to Collaborative Research Study, Hydrocephalus Association Commends Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... ranked #3 in the 2015 Best in KLAS: Software & Services for HIT ... annual Best in KLAS report independently ranks vendor performance by healthcare executives, managers ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Stuart Bentkover, ... technology, the PicoSure. Designed to provide the most effective tattoo removal today, Dr. Bentkover ... unmatched results. , Developed by Cynosure, the PicoSure has been approved by the Food ...
(Date:2/5/2016)... ... 05, 2016 , ... In sleep, when the defenses of the day are ... of patients with eating disorders is significant self-criticism, and consequently these patients experience this ... regarded as maladaptive means for coping with this unease, but also leads to a ...
(Date:2/5/2016)... ... February 05, 2016 , ... On June 9-10, Las ... continuing medical education (CME) event presented by the Association for Comprehensive Care in ... for ACCORD, whose mission is to provide education, tools, and resources to primary ...
(Date:2/5/2016)... ... ... –This week, Atascadero water heater company First Call Plumbing has ... the report, click here or see below. , There are two ... cons, the type chosen is almost entirely up to personal preference. However, tankless water ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  Syneron Medical Ltd. ... device company, announced today that William Griffing ... America, is scheduled to participate in the Leerink ... on February 11, 2016 in New ... institutional investors to meet with the Mr. Griffing ...
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/jsc97m/global ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, ... their offering. --> http://www.researchandmarkets.com/research/jsc97m/global ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, ... their offering. --> Research ...
(Date:2/5/2016)... , Feb. 5, 2016  Zimmer Biomet Holdings, Inc. ... the previously announced underwritten secondary offering of 11,027,558 shares ... consisting of affiliates of Blackstone and Goldman Sachs.  The ... initial price of $96.45 per share. The selling stockholders ...  Neither Zimmer Biomet nor any of its directors, officers ...
Breaking Medicine Technology: